Topics
Media
Pearls
Surveys
Conferences
Events
CME/CE
Resources
Subscribe

Spotlight -

Healthcare Careers|

Utilizing Medical Malpractice Data to Mitigate Risks and Reduce Claims

|Videos|September 24, 2021

What physicians need to know about the new ONC Information Blocking Rules

Author(s)Matthew Michela, Drew Boxler, Logan Lutton

What the new ONC Information Blocking rules say and why.

In this clip, Matthew Michela, president and CEO of Life Image, discusses what the new ONC Information Blocking rules say and why, according to Life Image survey results, most healthcare organizations may not be prepared for the implementation of these changes.

Newsletter

Optimize your practice with the Physicians Practice newsletter, offering management pearls, leadership tips, and business strategies tailored for practice administrators and physicians of any specialty.

Related Content

Olga Khabinskay

AI's hidden hand: Decoding prepayment denials and the evasion of high-dollar claims

ByOlga Khabinskay

November 7th 2025

Rachel V. Rose, JD, MBA

Learning moment: Medicaid fraud is still a priority

ByRachel V. Rose, JD, MBA

November 7th 2025

Neil Baum, M.D.

Putting fun in the medical practice: Hire for attitude, train for skills

ByNeil Baum, MD

November 7th 2025

Off the Chart: A Business of Medicine Podcast - Ep. 99: New lessons in lifestyle medicine, with Jennifer Trilk, Ph.D., FACSM, DipACLM

New lessons in lifestyle medicine, with Jennifer Trilk, Ph.D., FACSM, DipACLM

ByAustin Littrell

November 6th 2025

7 reasons your medical practice shouldn’t outsource | © Dzimitry - stock.adobe.com

7 reasons your medical practice shouldn’t outsource

ByKeith A. Reynolds

November 6th 2025

Latest CME

Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)

Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)

Anil K. Agarwal, MD, FACP, FASN, FNKF, FASDIN; Jay B. Wish, MD

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

Glenn M. Chertow, MD, MPH; Anjay Rastogi, MD, PhD

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Case-based Simulation

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Nicholas Doher, DO; Babak Tousi, MD

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Jeffrey A. Sparks, MD, MMSc

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Frank B. Cortazar, MD; Lindsay S. Lally, MD

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

© 2025 MJH Life Sciences^®

All rights reserved.